ALACRIS CMTA Trademark

Trademark Overview


On Monday, June 5, 2023, a trademark application was filed for ALACRIS CMTA with the United States Patent and Trademark Office. The USPTO has given the ALACRIS CMTA trademark a serial number of 98027963. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, September 3, 2024. This trademark is owned by Alacris Theranostics GmbH. The ALACRIS CMTA trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Diagnostic preparations and substances for medical purposes; Biological reagents for medical use; Chemical preparations for testing blood for medical purposes; Chemical preparations for use in DNA analysis, namely medical; Chemical reagents for medical use; Chemical test reagents, namely medical; Clinical diagnostic reagents for medical purposes; Clinical medical reagents; Diagnostic agents for medical use; Diagnostic agents for pharmaceutical use; Diagnostic biomarker reagents for medical purposes; Diagnostic chemical reagents for medical use; Diagnostic preparations for medical purposes; Diagnostic reagents for medical use; Diagnostic substances for medical use; Diagnostic testing materials for medical use, namely, medical diagnostic test media for gene sequencing of tumor samples, medical diagnostic test media for gene sequencing of blood samples, and medical diagnostic test media for gene sequencing of tissue samples; Immunoassay reagents for medical use; In vitro diagnostic prepar...

Advisory services relating to medical problems; Advisory services relating to medical services; Medical analysis of human serum for medical treatment purposes provided by medical laboratories; Medical analysis of human tissues for medical treatment purposes provided by medical laboratories; Breast cancer screening services; Bowel cancer screening services; Cervical cancer screening services; Collection and preservation of human blood; Compilation of medical reports, namely, providing medical information to patients in the form of reports in the field of molecular tumor analysis; Conducting of medical examinations; Health clinic services, namely medical; Genetic testing for medical purposes; DNA screening for medical purposes; Immunodetection services for medical purposes; Lung cancer screening services; Medical analysis services for cancer diagnosis and prognosis; Medical analysis services for the diagnosis of cancer; Medical analysis for the diagnosis and treatment of persons; Medical...

Analysis of human tissues for medical research; Research laboratory services in the field of cancer diagnostics; Scientific research for medical purposes in the area of cancerous diseases; Medical research laboratory services; Scientific investigations for medical purposes; Providing scientific information in the field of medical disorders and their treatment
alacris cmta

General Information


Serial Number98027963
Word MarkALACRIS CMTA
Filing DateMonday, June 5, 2023
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, September 3, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 9, 2024

Trademark Statements


Goods and ServicesDiagnostic preparations and substances for medical purposes; Biological reagents for medical use; Chemical preparations for testing blood for medical purposes; Chemical preparations for use in DNA analysis, namely medical; Chemical reagents for medical use; Chemical test reagents, namely medical; Clinical diagnostic reagents for medical purposes; Clinical medical reagents; Diagnostic agents for medical use; Diagnostic agents for pharmaceutical use; Diagnostic biomarker reagents for medical purposes; Diagnostic chemical reagents for medical use; Diagnostic preparations for medical purposes; Diagnostic reagents for medical use; Diagnostic substances for medical use; Diagnostic testing materials for medical use, namely, medical diagnostic test media for gene sequencing of tumor samples, medical diagnostic test media for gene sequencing of blood samples, and medical diagnostic test media for gene sequencing of tissue samples; Immunoassay reagents for medical use; In vitro diagnostic preparations for medical use; Biological indicators for medical diagnosis; Medical diagnostic reagents and assays for testing of body fluids; Preparations for detecting genetic predispositions for medical purposes; preparations consisting of pre-mixed reactants for medical diagnosis; Reagents for analytical purposes, namely for medical purposes; Reagents for blood grouping, namely for medical purposes; Reagents for in-vitro laboratory use, namely for medical purposes; Reagents for use in analysis, namely for medical purposes; Reagents for use with analyzers, namely for medical purposes; Reagents for use in diagnostic tests, namely for medical purposes
Goods and ServicesAdvisory services relating to medical problems; Advisory services relating to medical services; Medical analysis of human serum for medical treatment purposes provided by medical laboratories; Medical analysis of human tissues for medical treatment purposes provided by medical laboratories; Breast cancer screening services; Bowel cancer screening services; Cervical cancer screening services; Collection and preservation of human blood; Compilation of medical reports, namely, providing medical information to patients in the form of reports in the field of molecular tumor analysis; Conducting of medical examinations; Health clinic services, namely medical; Genetic testing for medical purposes; DNA screening for medical purposes; Immunodetection services for medical purposes; Lung cancer screening services; Medical analysis services for cancer diagnosis and prognosis; Medical analysis services for the diagnosis of cancer; Medical analysis for the diagnosis and treatment of persons; Medical care and analysis services relating to patient treatment; Medical counseling; Medical diagnostic services; Medical screening; Medical services in the field of oncology; Medical services for the treatment of skin cancer; Medical services for the diagnosis of conditions of the human body; Medical laboratory services for the analysis of samples taken from patients for diagnostic and treatment purposes; Medical laboratory services for the analysis of blood samples taken from patients for diagnostic and treatment purposes; Medical testing for diagnostic or treatment purposes; Medical testing services relating to the diagnosis and treatment of disease; Providing cancer screening services; Prostate cancer screening services; Preparation of reports providing medical information to patients relating to medical matters in the field of cancer diagnosis; Public health counseling; Provision of medical services; RNA or DNA analysis for cancer diagnosis and prognosis; Services for the testing of blood for diagnostic and treatment purposes provided by medical laboratories; Services for the testing of sera for diagnostic and treatment purposes provided by medical laboratories; Services for the testing of urine for diagnostic and treatment purposes provided by medical laboratories; Testicular cancer screening services; Next generation sequencing of tumor and control samples for diagnostic and treatment purposes provided by medical laboratories; Bioinformatic analysis of next generation sequencing data for pan-cancer diagnostics, provided by medical laboratories
Goods and ServicesAnalysis of human tissues for medical research; Research laboratory services in the field of cancer diagnostics; Scientific research for medical purposes in the area of cancerous diseases; Medical research laboratory services; Scientific investigations for medical purposes; Providing scientific information in the field of medical disorders and their treatment

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSunday, July 9, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSunday, July 9, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSunday, July 9, 2023
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAlacris Theranostics GmbH
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBerlin 12489
DE

Party NameAlacris Theranostics GmbH
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBerlin 12489
DE

Trademark Events


Event DateEvent Description
Thursday, June 8, 2023NEW APPLICATION ENTERED
Monday, February 26, 2024ASSIGNED TO EXAMINER
Sunday, July 9, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, March 5, 2024NON-FINAL ACTION WRITTEN
Tuesday, March 5, 2024NON-FINAL ACTION E-MAILED
Tuesday, March 5, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, May 29, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, May 29, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, May 29, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, May 30, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 19, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 9, 2024PUBLISHED FOR OPPOSITION
Tuesday, July 9, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 3, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT